← back to search

Peter Jung

Guy's and St Thomas' NHS Foundation Trust ·
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cancer-related Molecular Pathways, Cancer Cells and Metastasis, Bladder and Urothelial Cancer Treatments, and Cancer-related gene regulation.
h-index
29
citations
6,737
works
161
NIH funding
primary concept
email

Recent publications

Minimal vs Specialized Exercise Equipment for Pulmonary Rehabilitation
JAMA Network Open 2025cited by 5position: middledoi
Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy
Nature Cancer 2022cited by 131position: middledoi
SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis
Cancer Research 2022cited by 34position: lastdoi
AURKA is a prognostic biomarker for good overall survival in stage II colorectal cancer patients
Pathology - Research and Practice 2022cited by 11position: firstdoi
Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer
Cellular and Molecular Gastroenterology and Hepatology 2021cited by 30position: lastdoi
Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer
Cell Communication and Signaling 2020cited by 17position: lastdoi
Mixed large cell neuroendocrine carcinoma and squamous cell carcinoma of the colon: detailed molecular characterisation of two cases indicates a distinct colorectal cancer entity
The Journal of Pathology Clinical Research 2020cited by 9position: middledoi
Vitamin D differentially regulates colon stem cells in patient‐derived normal and tumor organoids
FEBS Journal 2019cited by 109position: middledoi
Targeting c-MYC through Interference with NAMPT and SIRT1 and Their Association to Oncogenic Drivers in Murine Serrated Intestinal Tumorigenesis
Neoplasia 2019cited by 13position: middledoi
Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells
Nature Communications 2018cited by 21position: middledoi
Australian and <scp>N</scp>ew <scp>Z</scp>ealand <scp>P</scp>ulmonary <scp>R</scp>ehabilitation <scp>G</scp>uidelines
Respirology 2017cited by 307position: middledoi
Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis
Gut 2016cited by 205position: middledoi
AP4 is a mediator of epithelial–mesenchymal transition and metastasis in colorectal cancer
The Journal of Experimental Medicine 2013cited by 149position: middledoi
AP4 directly downregulates p16 and p21 to suppress senescence and mediate transformation
Cell Death and Disease 2013cited by 39position: middledoi
Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation
Cancer Cell 2012cited by 1,068position: middledoi

Grants

Collaborative Research: Dynamic Regulation of Axonal Morphology by Neurofilament Transport
NSF1656765$345,0002017–2023PIRePORTER
Collaborative Research: Neurofilament Transport Kinetics and Axonal Morphology
NSF1146789$295,9892012–2016PIRePORTER
Collaborative: Modeling of Calcium Signaling Differentiation During Oocyte Maturation
NSF0744798$257,4572008–2012PIRePORTER
Collaborative Research: Role of Neurofilament Transport in the Growth of Axonal Caliber
NSF0818412$133,4972008–2012PIRePORTER
Neural-Glial Communication Networks: A Computational Approach
NSF0345500$481,5002004–2010PIRePORTER
Neural-Glial Signaling Deciphered by Hyper-Cluster Analysis
NSF0078055$348,6152000–2004PIRePORTER

Frequent collaborators

Jens Neumann · Hamburg Institute for Therapy Research6 papers (2013–2022)Heiko Hermeking · German Cancer Research Center6 papers (2013–2022)Thomas Kirchner · FH Aachen5 papers (2013–2022)Sophie Luise Boos · German Cancer Research Center4 papers (2018–2021) · 4 papers (2012–2022)René Jackstadt · German Cancer Research Center3 papers (2013–2018)David Horst · German Cancer Research Center3 papers (2013–2022) · 2 papers (2012–2022)Frederick Klauschen · Institute of Clinical Cancer Research2 papers (2022–2022) · 2 papers (2012–2022)Andreas Jung · University of Lübeck2 papers (2020–2021)Jörg Kumbrink · German Cancer Research Center2 papers (2020–2021)Marlies Michl · Praxis für Hämatologie und Onkologie2 papers (2020–2021)Roland Rad · Molecular Oncology (United States)2 papers (2019–2021)Matjaž Rokavec · Ludwig-Maximilians-Universität München2 papers (2021–2022)Leon P. Loevenich · Ludwig-Maximilians-Universität München2 papers (2021–2022)Antje Menssen · Max Planck Institute of Biochemistry2 papers (2013–2019) · 2 papers (2012–2022)Francisco M. Barriga · Centro de Investigación Biomédica en Red de Cáncer1 papers (2022–2022)Chris Newby · University of Leicester1 papers (2025–2025)